Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New market introduction for dorzolamide

Nov. 21, 1996

Oculex dexamethasone intraocular delivery system superior to eye drops

Nov. 20, 1996

InSite Vision strengthens position on genetic research into glaucoma

Nov. 1, 1996

Hybridon's VEGF-targeting antisense drugs for retinal neovascularization

Nov. 1, 1996

Ciba Vision licenses novel antiglaucoma agent from Ueno

Oct. 25, 1996

Revolutionary treatment for nearsightedness enters pivotal trials

Oct. 18, 1996

Sugen-Allergen collaboration in ophthalmic diseases

Oct. 18, 1996

New use for Uriach's rupatadine

Oct. 11, 1996

Anticataract and NGF production-enhancing compounds

Sep. 27, 1996

Wakamoto claims diclofenac eyedrop formulation

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...